Zimmer Biomet Holdings Inc (ZBH) : Welch Capital Partnersny reduced its stake in Zimmer Biomet Holdings Inc by 4.16% during the most recent quarter end. The investment management company now holds a total of 170,456 shares of Zimmer Biomet Holdings Inc which is valued at $20 Million after selling 7,402 shares in Zimmer Biomet Holdings Inc , the firm said in a disclosure report filed with the SEC on May 11, 2016.Zimmer Biomet Holdings Inc makes up approximately 7.36% of Welch Capital Partnersny’s portfolio.
Other Hedge Funds, Including , Azimuth Capital Management sold out all of its stake in ZBH during the most recent quarter. The investment firm sold 2,456 shares of ZBH which is valued $288,433.Columbia Partners L L C Investment Management boosted its stake in ZBH in the latest quarter, The investment management firm added 570 additional shares and now holds a total of 9,384 shares of Zimmer Biomet Holdings Inc which is valued at $1.1 Million. Zimmer Biomet Holdings Inc makes up approx 0.08% of Columbia Partners L L C Investment Management’s portfolio.Checchi Capital Advisers reduced its stake in ZBH by selling 456 shares or 20.52% in the most recent quarter. The Hedge Fund company now holds 1,766 shares of ZBH which is valued at $203,796. Zimmer Biomet Holdings Inc makes up approx 0.05% of Checchi Capital Advisers’s portfolio.Ingalls Snyder reduced its stake in ZBH by selling 323 shares or 1.4% in the most recent quarter. The Hedge Fund company now holds 22,710 shares of ZBH which is valued at $2.6 Million. Zimmer Biomet Holdings Inc makes up approx 0.16% of Ingalls Snyder’s portfolio.Tci Wealth Advisors boosted its stake in ZBH in the latest quarter, The investment management firm added 38 additional shares and now holds a total of 4,469 shares of Zimmer Biomet Holdings Inc which is valued at $517,376. Zimmer Biomet Holdings Inc makes up approx 0.28% of Tci Wealth Advisors’s portfolio.
Zimmer Biomet Holdings Inc opened for trading at $117.48 and hit $119.99 on the upside on Monday, eventually ending the session at $119.6, with a gain of 1.84% or 2.16 points. The heightened volatility saw the trading volume jump to 15,45,862 shares. Company has a market cap of $23,829 M.
On the company’s financial health, Zimmer Biomet Holdings Inc reported $2.00 EPS for the quarter, beating the analyst consensus estimate by $ 0.07 according to the earnings call on Apr 28, 2016. Analyst had a consensus of $1.93. The company had revenue of $1904.00 million for the quarter, compared to analysts expectations of $1878.31 million. The company’s revenue was up 67.8% compared to the same quarter last year. During the same quarter in the previous year, the company posted $1.54 EPS.
Many Wall Street Analysts have commented on Zimmer Biomet Holdings Inc. Company shares were Reiterated by Barclays on Apr 29, 2016 to “Overweight”, Firm has raised the Price Target to $ 135 from a previous price target of $130 .Company shares were Reiterated by RBC Capital Mkts on Apr 15, 2016 to “Outperform”, Firm has raised the Price Target to $ 132 from a previous price target of $120 .Zimmer Biomet Holdings Inc was Initiated by Nomura to “Buy” on Mar 17, 2016.
Zimmer Biomet Holdings Inc. formerly Zimmer Holdings Inc. is a musculoskeletal healthcare company. The Company designs manufactures and markets orthopedic reconstructive products; sports medicine biologics extremities and trauma products; spine bone healing craniomaxillofacial and thoracic products; dental implants and related surgical products. The Company manages its operations through three geographic segments: the Americas comprising principally of the United States and includes other North Central and South American markets; Europe comprising principally of Europe and includes the Middle East and African markets; and Asia Pacific comprising primarily of Japan and includes other Asian and Pacific markets. The Company markets and sells products through three channels: direct to healthcare institutions such as hospitals or direct channel accounts; through stocking distributors and healthcare dealers and directly to dental practices and dental laboratories.